Viridian Therapeutics Ors Inc (VRDN)
$24.67 -0.52% Close Oct 30, 2026 Live
Viridian Therapeutics Ors stock today
Viridian Therapeutics Ors closed at $24.67 on October 30, 2026, down 0.52% on the day. Over the past year it returned +4.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.54 billion.
$20.00$30.00
NovJan 2026MarMayJulSep
| Period | VRDN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +19.8% | -0.9% |
| 3 months | +24.0% | +2.1% |
| Year to date | -20.7% | +11.7% |
| 1 year | +4.3% | +12.4% |
| 3 years | +89.5% | +88.5% |
| 5 years | +36.3% | +76.0% |
Key statistics
- Market value
- $2.54B
- Price / sales
- 35.8
- 52-week range
- $13.30 to $33.78
- Next report
- Nov 4, 2026
About Viridian Therapeutics Ors
Biopharmaceutical company developing therapeutics for endocrine and metabolic diseases.
Sector: Health Care
More on Viridian Therapeutics Ors
- Financials: revenue, earnings and segmentsRevenue +23,360% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $328.97 today
No forecast, no recommendation. This page describes Viridian Therapeutics Ors Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.